First electronic product information (ePI) published for selected human medicines

Maximum residue limits (MRL)

Availability of veterinary vaccines

Union Product Database

Advice on impacts of using antimicrobials in animals

European Surveillance of Veterinary Antimicrobial Consumption (ESVAC)

Human medicines European public assessment report (EPAR): Relvar Ellipta, fluticasone furoate,vilanterol, Pulmonary Disease, Chronic Obstructive, Date of authorisation: 13/11/2013, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Fasenra, benralizumab, Asthma, Date of authorisation: 08/01/2018, Revision: 13, Status: Authorised

Public health threats

Human medicines European public assessment report (EPAR): Degarelix Accord, degarelix, Prostatic Neoplasms, Date of authorisation: 29/09/2023, Status: Authorised